口服普萘洛尔治疗婴幼儿血管瘤的疗效评价

›› 2016, Vol. 36 ›› Issue (1): 50-53.

口服普萘洛尔治疗婴幼儿血管瘤的疗效评价

赵志国¹,赵扬²,林枫¹,张力平¹

1. 中国医科大学附属盛京医院
2. 沈阳药科大学

收稿日期:2015-06-01 修回日期:2015-07-02 出版日期:2016-01-28 发布日期:2016-01-08
通讯作者: 赵志国 E-mail:zhaozg@sj-hospital.org
基金资助:
辽宁省科学技术计划

Evaluation on efficacy of oral propranolol in treatment of infantile hemangioma

Received:2015-06-01 Revised:2015-07-02 Online:2016-01-28 Published:2016-01-08
Contact: Zhi-Guo ZHAO E-mail:zhaozg@sj-hospital.org

摘要/Abstract

摘要： 目的　评价普萘洛尔治疗婴幼儿血管瘤的临床疗效和安全性。方法　2012年3月至2014年3月，对确诊为婴幼儿血管瘤的49例患儿采用口服普萘洛尔2.0 mg/（kg?d）治疗，分两次服用，40例患儿采取局部注射平阳霉素作对照。每3～4周复诊一次，动态观察血管瘤的体积变化及不良事件发生率，整个治疗过程直到病变没有改善为止，根据Achauer疗效判定标准对治疗效果进行评价。结果　普萘洛尔组患儿Ⅰ级3例,Ⅱ级6例,Ⅲ级16例,Ⅳ级24例，总有效率为93.88%，平阳霉素组患儿Ⅰ级9例,Ⅱ级11例,Ⅲ级13例,Ⅳ级7例，总有效率为77.50%，普萘洛尔组疗效优于平阳霉素组（P＜0.05）。普萘洛尔组不良事件发生率6.12%，平阳霉素组不良事件发生率10.00%。结论　普萘洛尔口服治疗婴幼儿血管瘤方法有效，不良事件发生率低。

关键词: 血管瘤, 普萘洛尔, 平阳霉素

Abstract: Objective To estimate the efficacy and safety of oral propranolol in treatment of infantile hemangioma. Methods From Mar., 2012 to Mar., 2014, 49 children with infantile hemangioma were selected as experiment group by using propranolol at a dose of 2.0 mg/(kg?d-1), twice a day; 40 children with infantile hemangioma were selected as control group by undergoing intralesional injection with pingyangmycin. The changes of the hemangioma size and the incidence of adverse reactions were recorded every 3 to 4 weeks. The entire process lasted until the lesion did not change. Efficacy was evaluated by using Achauer system. Results In propranolol group, the total effective rate was 93.88%, including 3 cases of classⅠ(poor), 6 cases of classⅡ(moderate), 16 cases of classⅢ(good), and 24 cases of classⅣ(excellent); In pingyangmycin group, the total effective rate was 77.50%, including 9 cases of classⅠ(poor), 11 cases of classⅡ(moderate), 13 cases of classⅢ(good), and 7 cases of classⅣ(excellent). The efficacy in propranolol group was significantly better than that in pingyangmycin group (P＜0.05). The incidence of adverse reactions in propranolol group (6.12%) was lower than that in pingyangmycin group (10.00%). Conclusion Oral propranolol is effective in treatment of infantile hemangioma, with a low incidence of adverse reactions.

Key words: hemangioma, propranolol, pingyangmycin

中图分类号:

R732.2

赵志国赵扬林枫张力平. 口服普萘洛尔治疗婴幼儿血管瘤的疗效评价[J]. , 2016, 36(1): 50-53.

参考文献

[1] Shah S, Frieden IJ. Treatment of infantile hemangiomas with Beta-blockers: a review[J].Skin Therapy Lett,2013,18(6):5-7.
[2] 郑家伟.婴幼儿血管瘤“等待观察”的治疗策略应予改变[J].中国口腔颌面外科杂志,2012,10(2):163-164.
[3] 张继斌，刘军，陈松龄.婴幼儿腮腺血管瘤的治疗探讨[J].口腔医学，2014，34（7）：555-557.
[4] Fuchsmann C, Quintal MC, Giguere C, et al. Propranolol as first-line treatment of head and neck hemangiomas[J].Arch Otolaryngol Head Neck Sury,2011,137(5):471-478.
[5] Bruckner A L, Frienden I J. Hemangiomas of infancy[J].J Am Acad Dermatol,2003,48(4):477-493.
[6] Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients[J].Plast Reconstr Surg,1997,99(5):1301-1308.
[7] Chang LC, Haggstrom AN, Drolet BA, et al. Growth characterisities of infantile hemangiomas: implications for management[J].pediatries,2008,122(2):360-367.
[8] 王绪凯.脉管性疾病的治疗[J].中国实用口腔科杂志,2009,2(5):280-282.
[9] Price CJ, Lattouf C, Baum B, et al. Propranolol vs corticosteroids for infantile hemangiomas: a multicentre retrospective analysis[J].Arch Dermatol,2011,147(12):1371-1376.
[10] Tan BH, Leadbitter PH, Aburn NH, et al. Steroid therapy for problematic proliferating haemangioma[J].N Z Med J,2011,124(1329):57-65.
[11] Zimmermann AP，Wiegand S, Werner JA, et al. Propranolol therapy for infantile haemangiomas: review of literature [J].Int J Pediatr Otorhinolaryngol,2010,74(4):338-342.
[12] Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas[J].Pediatrics,2011,128:e259-266.
[13] Hermans, Bauland, Zweegers, et al. Propranolol in a case series of 174 patients with complicated infantile haemangiomas: indications, safety and future directions[J].British Journal of Dermatology,2013,168:837-843.
[14] Pope E, Chakkittakandiyil A, Lara-Corrales I,et al. Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolo compared with propranolol[J].Br J Dermatol,2013,168:222-224.
[15] 郑家伟,马坤宁,张凌.婴幼儿血管瘤药物治疗概述[J].中国口腔颌面外科杂志,2014,12(1):1-6.
[16] Hou J, Wang M, Tang H, et al. Pingyangmycin sclerotherapy for infantile haemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients [J].Int J Oral Maxillofac Surg. 2011,40(11):1246-1251.